Filing Details
- Accession Number:
- 0001104659-20-078440
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-30 08:19:11
- Reporting Period:
- 2020-06-29
- Accepted Time:
- 2020-06-30 08:19:11
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1579428 | Axsome Therapeutics Inc. | AXSM | Pharmaceutical Preparations (2834) | 454241907 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1742143 | Nick Pizzie | C/O Axsome Therapeutics, Inc. 200 Broadway, 3Rd Floor New York NY 10038 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-06-29 | 777 | $76.64 | 41,217 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 60 | Indirect | By UTMA account |
Footnotes
- 777 shares were purchased by the Reporting Person's IRA.
- Represents 60 shares of common stock indirectly held by the reporting person as custodian for his son's UTMA account. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.